# S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

> **NCT00243074** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 54 (actual)

## Conditions studied

- Advanced Malignant Mesothelioma
- Epithelial Mesothelioma
- Recurrent Malignant Mesothelioma
- Sarcomatous Mesothelioma

## Interventions

- **DRUG:** cediranib maleate
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00243074
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2010-04
- **Final completion:** 2011-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243074, "S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00243074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*